ARSYNL Rx review
By The Dose Brief DeskUpdated
ARSYNL Rx now lists monthly injection plans and a separate transdermal option; tirzepatide ingredient wording and refill terms need checking.
- Semaglutide
Injection page advertises $219/month
One-month compounded semaglutide + B12 plan; medication, provider review, supplies and delivery described included.
Selected dose and supplied quantity unconfirmed; earlier $233/month listing is historical. Exact refill cancellation deadline needs confirmation.
Full price details
Compounded semaglutide injection offered; complete selected-prescription quote unknown; current product page advertises $219/month one-month plan with medication and care, while earlier listing from $233/mo is historical
- Tirzepatide
Injection page advertises $269/month
One-month plan; product title says B12 while treatment body says B6. Confirm exact formulation and supplied quantity.
Earlier $366/month listing is historical. Transdermal spray is separate: $269/month or $759 once for three months, with a four-week bottle described.
Full price details
Compounded tirzepatide injection offered; exact added ingredient and complete selected-prescription quote unknown; current injection page advertises $269/month one-month plan but title says B12 and body says B6; earlier listing from $366/mo is historical
- Coverage
- U.S. service advertised; eligibility restrictions vary by therapy, medication and patient state
- Brand-name
- References to Wegovy, Ozempic, Mounjaro or Zepbound ingredients and trial results do not establish an advertised branded prescribing program.
Prices checked against ARSYNL Rx's published terms in . Providers change pricing without notice — check the current figure before you buy.
ARSYNL Rx in depth
Monthly injection plans have changed
ARSYNL Rx's current semaglutide page (opens in a new tab) advertises a compounded weekly injection at $219 per month on a one-month plan. Its tirzepatide injection page (opens in a new tab) shows $269 per month. Both describe medication, provider review, supplies and delivery without a separate membership fee. Confirm the selected protocol and actual quantity; neither an earlier price nor a catalog price range establishes today's individual order.
The tirzepatide product needs an ingredient check before purchase. Its title says B12, but its main treatment explanation repeatedly says B6. Semaglutide is described with B12. Ask the prescriber and pharmacy to identify the exact formulation, concentration and supplied quantity rather than choosing from the title. The pharmacy checklist covers the details that should match the prescription and label.
The spray is a separate treatment route
ARSYNL separately markets tirzepatide HypoSpray as a transdermal spray. That page advertises $269 monthly or $759 paid once for three months, alongside a statement that one bottle supplies four weeks. This is not the weekly injection and should not be presented as an interchangeable version of it. Discuss the route and evidence with the prescriber instead of relying on the page's branded-dose equivalence comparisons.
The spray's monthly billing language and four-week bottle description also deserve clarification before a longer commitment. At WellMedr, too, both plans ship every four weeks, so its monthly figures also need checking against the supply period. Our billing guide explains why the shipment schedule, full payment and supplied period must be compared together. A generic oral-format selector elsewhere on the page does not establish a specific oral GLP-1 product or a current branded prescription option.
Refill notice is not a refund promise
The FAQ (opens in a new tab) says availability varies by therapy and state and lists Manifest Pharmacy and RX Compounding Store as possible dispensing partners. It also allows a local-pharmacy request, without guaranteeing the same price. Those are possible facilities, not an assignment to every prescription. Confirm the clinician, chosen pharmacy, available formulation and total payment for your location before ordering.
The FAQ says patients are contacted before a refill is billed. The refund page (opens in a new tab) says prescription medicines cannot be returned after dispensing and sales are final once payment is charged and the parcel is handed to the carrier. It describes cancellation before shipment but gives no precise advance deadline. Our refund guide helps separate a future-refill cancellation from any request to recover an already-dispensed order.
Sources we checked
Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.
This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.
- Current semaglutide plan and formulation (opens in a new tab)
- Injection price and conflicting B12/B6 wording (opens in a new tab)
- Separate spray route, monthly/quarterly payment and four-week bottle (opens in a new tab)
- State restrictions, pharmacy choices and refill notice (opens in a new tab)
- Prescription refund milestones and cancellation (opens in a new tab)
The scorecard
ARSYNL Rx scored on our six Brief Score factors. See the methodology.
What we like
- Current injection pages distinguish monthly payment from catalog ranges
- Names possible pharmacies and allows local-pharmacy requests
- Separates injection and transdermal treatment pages
The caveats
- Tirzepatide title and body disagree on B12 versus B6
- Four-week spray supply is shown alongside monthly billing
- Exact refill cancellation deadline and selected prescription need confirmation
The brief
Best for: Readers comparing a clearly identified injection with other advertised routes who will verify the formulation and refill agreement. ARSYNL Rx now lists monthly injection plans and a separate transdermal option; tirzepatide ingredient wording and refill terms need checking.
Ranked #305 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.
Before you decide
The questions readers ask next after reading about ARSYNL Rx.
Closest here
The providers scoring nearest ARSYNL Rx — read each current assessment before choosing care.
Weighing ARSYNL Rx against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs ARSYNL Rx, and every provider that outranks it is listed on the ARSYNL Rx alternatives ranking.
- #302TeleHealth Med— TeleHealth Med advertises bundled weight care, but the current medication quote, guarantee exclusions and subscription cutoff need clarification.64/100
- #303Zappy Health— Zappy Health publishes monthly rates and prepaid starter packs. Its separate cancellation pages describe different conditions.64/100
- #304AMP Health— AMP Health’s public site displays a maintenance notice. Current GLP-1 prices and enrollment could not be verified.Historical: 63/100
- #306Bliv— Bliv publishes low starting figures, but the selected term, medication payment and separate clinical refund rules need checking.63/100
- #307Bon Health— Bon Health separates monthly plans from prepaid annual savings; the governing patient refund agreement still needs confirmation.63/100
- #308Fidelity Medical Clinic— Fidelity offers Florida-focused injection and oral care, but the semaglutide starter headline and dose-supply table need reconciliation.63/100
More providers we track (24)
- #1 CoreAge Rx94
- #2 Eden91
- #3 Sesame Care87
- #4 ShedRx87
- #5 Trimi89
- #6 HealthRX86
- #7 Sprout Health86
- #8 Invigor Medical88
- #9 REMEVi87
- #10 Ro87
- #11 Ondra Health87
- #12 Vaylen87
- #13 Vytora Health87
- #14 No BS RX87
- #15 yourEra84
- #16 Strut Health84
- #17 Effecty86
- #18 NiceRx86
- #19 Curex86
- #20 Amazon One Medical86
- #21 MadeMed86
- #22 Telos Rx85
- #23 Enhance MD85
- #24 AgelessRx85
514 more are filed too — see every provider we track, ranked.
Pricing, states and verification reflect ARSYNL Rx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on ARSYNL Rx's site. Not medical advice; see our disclosure.